Alprazolam C-IV 2 mg — Class II drug recall D-0651-2022
Terminated recall by Direct Rx, reported 2022-03-16, distributed in FL, GA, LA. CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Ta
| Recall number | D-0651-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Direct Rx, Dawsonville, GA, United States |
| Recall initiated | 2022-03-04 |
| Classified | 2022-03-10 |
| Reported by FDA | 2022-03-16 |
| Terminated | 2022-12-02 |
| Distributed | FL, GA, LA |
| Quantity | 8 bottles |
| Reason classes | cgmp |
| NDC | 72189-0058-60 |
| Lot numbers | 07NO1901 |
| Expiration dates | 2022-05-31 |
Product
Alprazolam C-IV 2 mg, 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0058-60
Reason for recall
CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0651-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.